Why Cassava Sciences Stock Is Skyrocketing Today

Barry was appointed as Cassava's executive chairman on July 17, 2024. He has served on the biopharmaceutical company's board of directors since June 2021. Barry is leading Cassava as it searches for a new CEO following former CEO Remi Barbier's resignation last week. Is Cassava Sciences stock a buy after its rebound? Why did investors like what Cassava's new executive chairman said? Despite the strong gains today, Cassava Sciences' share price is still down more than 40% year to date. Is the beaten-down bio ...